Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219251 · ClinicalTrials.gov registry record · NA
Engagement of Veterans With Lung Cancer
A NA study of Lung Carcinoma and Lung Cancer, Non-Small Cell, sponsored by Palo Alto Veterans Institute for Research.
- Recruiting
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 1
- Study location
NCT07219251: Recruiting NA study of Lung Carcinoma and Lung Cancer, Non-Small Cell, sponsored by Palo Alto Veterans Institute for Research.
NCT07219251 is a NA study of Lung Carcinoma and Lung Cancer, Non-Small Cell that is actively recruiting participants, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 194 participants, below the 5,039-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219251, a NA study of Lung Carcinoma and Lung Cancer, Non-Small Cell, is actively recruiting participants, sponsored by Palo Alto Veterans Institute for Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Primary Outcome
Change in Health-related quality of life using the 36-item validated Functional Assessment of Cancer Therapeutics-Lung (FACT-L) survey.
Conditions Studied
Interventions
- OTHER Usual Care Group
- BEHAVIORAL Lay Health Worker (LHW) Planning
Study Locations (1)
California
- Veterans Affairs Palo Alto Health Care System (VAPAHCS) - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2032-12-31 |
| Phase | NA |
What NCT07219251 shows while recruiting
NCT07219251 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 5,039-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (96% lower).
The record links to 6 conditions, with Lung Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Group is the first listed.
NCT07219251 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07219251 about?
NCT07219251 is a clinical study titled "Engagement of Veterans With Lung Cancer". This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
What is the current status of trial NCT07219251?
This trial is currently recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2026-02-27. Estimated completion is 2032-12-31.
What conditions does trial NCT07219251 study?
This clinical trial studies the following conditions: Lung Carcinoma, Lung Cancer, Non-Small Cell, Lung Adenocarcinoma, Lung Cancer (NSCLC), Lung Cancer, Small Cell.
What interventions are being tested in trial NCT07219251?
The interventions under investigation include: Usual Care Group (OTHER), Lay Health Worker (LHW) Planning (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219251?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219251 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219251's enrollment target sits among peer trials
194 15th of 38 higher than 24 of 38 other Lung Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
RECRUITING · NA
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
RECRUITING · NA
-
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI